Skip to main content

Members

Members (9)

From across Europe and beyond, and from a variety of backgrounds, our members share many common goals. Our members’ diversity, expertise and openness to collaborate is our strength. Search our members list here. Filter using our search options. All members are encouraged to network and develop as a community that fosters collaboration. Find your match, share, engage and complement expertise.

Showing 1-9 of 9 members.

Matvey Sprindzuk

Business enterprise
Home country
Belarus
Type of research activities
Applied research, Basic research, Experimental development
Fields of research
Natural sciences, Engineering and technology, Medical and health sciences
Specialisation and expertise
Bioinformatics, genomics, medicine, virology, microbiology, image processing, AI, software engineering, COVID-19, tuberculosis, mathematical modelling, applied mathematics, medical systems, data processing automation
Language(s)
English

SHINE 2Europe, Lda

Business enterprise
Home country
Portugal
Type of research activities
Applied research, Basic research, Experimental development
Fields of research
Psychology and cognitive sciences, Economics and Business, Education, Sociology, Law, Political science, Other social sciences, Medical and health sciences, Humanities and the arts
Specialisation and expertise
SHINE's main goal is to promote inclusive societies for all. This includes gender, race, age, personal opinions and lifestyles, literacy, environment and sustainability, with shared responsibility between all citizens and within democratic values. This is not restricted to awareness raising, advocating for the most fragile citizens or calling up the public attention to all the needs for extra care and specific interventions. What we really foster is to help imagining a society that is already built taking into consideration the different needs of all citizens and creating holistic solutions that can help them to be happy and have a fulfilled life. In this concept we include: • strengthening organisations roles and initiatives that enhance inclusion, active and participatory citizenship, human rights, health and care for the frailest, quality education and training. • promoting entrepreneurship, sustainable innovation and market outreach, through targeted impacts on different ecosystem layers. • directly engaging with stakeholders, end-users and citizens in co-creating, experimenting and validating innovative ideas and products, favouring citizen involvement in public decision-making. • creating training materials and tools that promote lifelong learning and self-development, peer-learning and enhanced literacy and skills in different target groups. • advancing knowledge on age-friendly, inclusive, green and tech-savvy societies, promoting research and publications on these themes. • on a higher level, working in strategies, policies and participatory approaches that lead to a better democratic process, empowering citizens and engaging the whole cycle of stakeholders. Bringing innovation, digital solutions, social inclusion and a greener environment is often mainly dependent of policy change. With all the differences between regions, countries and public systems, one size does not fit all. Policy change requires a complex, bureaucratic and long process, implies connecting a broad network of actors and moreover, implies finding public commitments, which is not simple or easy. SHINE’s team has a solid experience and a wide network of contacts both in national and international contexts, that ensure the better way through to build policy claims. Although this is not the core focus of SHINE, the creation, development or adaptation of simple IT solutions is also one of our key assets. Whenever it makes sense to provide an integrated solution for a societal challenge that can be adequately addressed by a digital product, e.g. an app, a game or a platform, SHINE has the expertise to deliver it too. What are the gains? We can talk both languages and approach the different worlds - technological, societal and research and bridge the gap that so many times makes innovation fail in the final run. Key areas of expertise • Ethical excellence • Co-creation and stakeholder engagement, citizen science, RRI • Policy recommendations • Training, literacy and citizen empowerment • Societal impact analysis • Dissemination and outreach • Entrepreneurship and sustainable innovation • Health and digital solutions • Data sharing governance
Language(s)
English, Portuguese

Gurila

Business enterprise
Home country
Georgia
Type of research activities
Applied research, Basic research, Experimental development
Fields of research
Economics and Business, Natural sciences, Medical and health sciences
Specialisation and expertise

We are the developer of an innovative technology for the production of a completely new highly effective active substance. These regenerating products are extremely effective in treatment of liver cirrhosis of various etiologies previously officially considered incurable (ascites goes away after 15 days, cirrhosis changes into fibrosis after 30-50 days, the period of complete hepatic regeneration is about 4 months). They are also effective against genital herpes virus (4-6 months), effective against hepatitis of various etiologies, including such as B, C, D ( viral load is reduced by half every 26 days, after a course of therapy, the virus is not detected in the blood, the patient ceases to be a virus carrier), drugs restore the liver in case of fatty hepatosis, pulmonary tuberculosis including MDR TB/ XDR TB (after 26 days an active form of stage 4 changes into stage 2-3 of latent form), lymphosarcoma, fibroma, myoma and pyelonephritis. The drugs prevent diabetic foot gangrene extremities. After the therapy patients no longer need previously recommended heart bypass surgery. The drug restores the function of the pancreas, and gives a complete restoration of long-term erectile dysfunction. The condition of patients with Alzheimer disease, Down's syndrome, encephalopathy, encephalitis and other diseases improves significantly without any side effects. The drugs have a strong antifibrotic effect, they dissolve scars on heart after myocardial infarction. Heart tissue completely regenerates within 6 months. This is only what we have studied so far.  We have strong assumptions that our medications can also effectively affect the activity of the COVID-19 coronavirus, as well as other viruses and infections. We are interested in partners and research of our drugs.

Language(s)
Russian, English, Spanish, French

PREDICTA S.A.

Business enterprise
Home country
Greece
Type of research activities
Applied research, Basic research
Fields of research
Economics and Business, Engineering and technology, Medical and health sciences
Specialisation and expertise

Consulting / Advisory Services areas: • Big Data Strategy design • Analytics Applications’ roadmap design • Wider Analytics technology infrastructure architectural design and implementation • Analytics’ neighboring domains roadmap design, i.e. Loyalty Scheme design and implementation, Marketing Automation/Campaign Management systems, Mobile Applications’ hosting/integrating technologies, … Professional Implementation Services Generic Analytics Applications & Methodologies: • Value-based Segmentation or/and RFM Analysis • Behavioral Segmentation Analysis • Strategic Segmentation Analysis • Next Best Offer Analysis • Cross/Up/Deep-Selling Propensity Modeling • Early Warnings on Signs of Customers’ Defection Analysis • Anti-Attrition / Churn Propensity Modeling • Social Network Analysis (SNA) • Forecasting Analysis • Credit Risk Modeling (PD, LGD, …) • Pre-Collections & Collections Modeling Industry-specific Analytical Solutions: • Total Enterprise Streamlined Customer Management for Next Best Action (NBA) • Performance Forecasting & Distribution Network Target Allocation • Customer Lending Optimization (CLO) • Geolocation Analytics for Cards’ transactions’ boosting, penetrating loyalty partners’ network (merchants) • Customer “Digitalization” Solution • Customer Onboarding Strategy Solution • Complaints Management via Text Analytics • Streamlined solution for IFRS9 Risk Regulatory Framework compliance and overall processes management.

Language(s)
English

Covidpedia Labs

Business enterprise
Home country
Belgium
Type of research activities
Applied research, Basic research, Experimental development
Fields of research
Education, Sociology, Political science, Media and communications, Medical and health sciences, Humanities and the arts
Specialisation and expertise
Covidpedia Labs is an extensive platform on the COVID-19 pandemic - the platform distils and detangles information that is misleading or intentionally disinforming people; releases up to date information on the pandemic; and scientific reporting.
Language(s)
English, English, French
The portal is now open.

Join this community of researchers, publish your member profile and team up for new collaboration opportunities.

Become a member